These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20202200)

  • 1. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Giant racemose subarachnoid and intraventricular neurocysticercosis: A case report].
    Sanchez-Larsen A; Monteagudo M; Lozano-Setien E; Garcia-Garcia J
    Rev Argent Microbiol; 2015; 47(3):201-5. PubMed ID: 26321177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case from India of neurocysticercosis responsive to albendazole treatment.
    Zardi EM; Petrarca V; Pozio E; Uwechie V; Tamburrini A; Laghi V
    Parasite; 2000 Mar; 7(1):54-6. PubMed ID: 10743650
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinsonism associated with neurocysticercosis.
    Sá DS; Teive HA; Troiano AR; Werneck LC
    Parkinsonism Relat Disord; 2005 Jan; 11(1):69-72. PubMed ID: 15619466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary extensive spinal subarachnoid cysticercosis.
    Shin SH; Hwang BW; Lee SJ; Lee SH
    Spine (Phila Pa 1976); 2012 Sep; 37(19):E1221-4. PubMed ID: 22588382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
    Romo ML; Carpio A; Kelvin EA
    J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle.
    Proaño JV; Madrazo I; García L; García-Torres E; Correa D
    J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of neurocysticercosis.
    Garg RK
    Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology].
    Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P
    Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis].
    Alla P; Carli P; Paris JF; Chagnon A
    Med Trop (Mars); 1996; 56(3):308. PubMed ID: 9026603
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
    Kaur S; Singhi P; Singhi S; Khandelwal N
    Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural History of Treated Subarachnoid Neurocysticercosis.
    Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
    Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocysticercosis in Wisconsin: 3 cases and a review of the literature.
    Naddaf E; Seeger SK; Stafstrom CE
    WMJ; 2014 Apr; 113(2):74-8; quiz 79. PubMed ID: 24908903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Be careful while using albendazole/praziquantel in neurocysticercosis.
    Garg RK; Uniyal R; Malhotra HS
    Neurol India; 2017; 65(4):924-926. PubMed ID: 28681797
    [No Abstract]   [Full Text] [Related]  

  • 20. Subarachnoidal and intraventricular human neurocysticercosis: application of an antigen detection assay for the diagnosis and follow-up.
    Bobes RJ; Hernández M; Márquez C; Fragoso G; García E; Parkhouse RM; Harrison LJ; Sciutto E; Fleury A
    Trop Med Int Health; 2006 Jun; 11(6):943-50. PubMed ID: 16772017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.